Atherosclerosis Cardiovascular Disease Clinical Trials

7 recruitingLast updated: June 20, 2026

There are 7 actively recruiting atherosclerosis cardiovascular disease clinical trials across 40 countries. Studies span Phase 2, Not Applicable, Phase 3, Phase 4. Top locations include Brisbane, Australia, Dalian, China, Amsterdam, Netherlands. Updated daily from ClinicalTrials.gov.


Atherosclerosis Cardiovascular Disease Trials at a Glance

7 actively recruiting trials for atherosclerosis cardiovascular disease are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Brisbane, Dalian, and Amsterdam. Lead sponsors running atherosclerosis cardiovascular disease studies include Atom Therapeutics Co., Ltd, Eli Lilly and Company, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse atherosclerosis cardiovascular disease trials by phase

Treatments under study

About Atherosclerosis Cardiovascular Disease Clinical Trials

Looking for clinical trials for Atherosclerosis Cardiovascular Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Atherosclerosis Cardiovascular Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Atherosclerosis Cardiovascular Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled568 locationsNCT07241390
Recruiting
Phase 2

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

ASCVDAtherosclerosis Cardiovascular DiseaseASCVD Management
Atom Therapeutics Co., Ltd200 enrolled33 locationsNCT07303777
Recruiting

Oral Microbiome in Carotid Atherosclerosis

PeriodontitisAtherosclerosis Cardiovascular DiseaseAtherosclerosis of Artery+2 more
Semmelweis University Heart and Vascular Center200 enrolled1 locationNCT07296965
Recruiting
Not Applicable

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

ObesityMetabolic SyndromeInflammation+5 more
University of Seville8 enrolled1 locationNCT07361887
Recruiting

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

Type 2 DiabetesCoronary Artery Disease (CAD)Atherosclerosis Cardiovascular Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,000 enrolled2 locationsNCT07237685
Recruiting
Phase 2

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

Atherosclerosis Cardiovascular DiseaseStroke (CVA) or TIACarotid Artery Plaque+1 more
Universitaire Ziekenhuizen KU Leuven24 enrolled1 locationNCT07104487
Recruiting
Phase 4

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

chronic coronary artery diseaseStable Angina PectorisCoronary Artery Disease+3 more
Tina Vilsbøll124 enrolled3 locationsNCT06606821